Faron Pharmaceuticals Oy is up 12%, leading the way for the Biotech industry, which has gained 1.9%. In contrast, the industry has lost 13% in the last 12 months. Looking forward, earnings are forecast to grow by 32% annually.
Has the U.K. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 31 May 2025 | UK£2.5b | UK£878.9m | -UK£89,048,731.00 | 13.9x | -27.6x | 2.8x |
Mon, 28 Apr 2025 | UK£2.1b | UK£876.5m | -UK£171,010,503.11 | 17.2x | -12.3x | 2.4x |
Wed, 26 Mar 2025 | UK£2.4b | UK£844.1m | -UK£277,247,408.91 | 17.1x | -8.5x | 2.8x |
Fri, 21 Feb 2025 | UK£2.6b | UK£841.6m | -UK£293,966,421.10 | 82.6x | -8.9x | 3.1x |
Sun, 19 Jan 2025 | UK£2.7b | UK£842.7m | -UK£297,345,767.12 | 85.2x | -9.2x | 3.2x |
Tue, 17 Dec 2024 | UK£2.7b | UK£841.5m | -UK£293,734,272.25 | 79x | -9.1x | 3.2x |
Thu, 14 Nov 2024 | UK£2.8b | UK£840.8m | -UK£293,945,911.99 | 86.4x | -9.4x | 3.3x |
Sat, 12 Oct 2024 | UK£2.9b | UK£840.2m | -UK£295,599,113.82 | 97.1x | -10x | 3.5x |
Mon, 09 Sep 2024 | UK£2.7b | UK£830.5m | -UK£314,446,085.32 | 82.9x | -8.7x | 3.3x |
Wed, 07 Aug 2024 | UK£2.6b | UK£838.4m | -UK£258,170,344.88 | 30.3x | -10x | 3.1x |
Fri, 05 Jul 2024 | UK£2.6b | UK£835.6m | -UK£260,791,630.77 | 30.3x | -10.1x | 3.1x |
Sun, 02 Jun 2024 | UK£3.0b | UK£836.3m | -UK£287,266,028.40 | 30.6x | -10.3x | 3.6x |
Tue, 30 Apr 2024 | UK£3.2b | UK£895.7m | -UK£215,376,495.24 | 31.2x | -14.7x | 3.5x |
Thu, 28 Mar 2024 | UK£3.1b | UK£903.1m | -UK£202,126,857.04 | 28.4x | -15.3x | 3.4x |
Sat, 24 Feb 2024 | UK£3.3b | UK£896.7m | -UK£197,698,774.85 | 32.6x | -16.7x | 3.7x |
Mon, 22 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,297,001.00 | 37.3x | -25.9x | 5x |
Wed, 20 Dec 2023 | UK£6.2b | UK£1.3b | -UK£245,101,181.00 | 37.5x | -25.4x | 4.9x |
Fri, 17 Nov 2023 | UK£6.5b | UK£1.3b | -UK£242,542,229.00 | 38.6x | -26.6x | 5.1x |
Sun, 15 Oct 2023 | UK£6.6b | UK£1.3b | -UK£251,303,385.00 | 38.4x | -26.1x | 5.1x |
Tue, 12 Sep 2023 | UK£6.6b | UK£1.3b | -UK£206,702,008.00 | 23.6x | -31.7x | 5.1x |
Thu, 10 Aug 2023 | UK£6.8b | UK£1.3b | -UK£207,967,768.00 | 23.6x | -32.5x | 5.4x |
Sat, 08 Jul 2023 | UK£6.7b | UK£1.3b | -UK£208,510,181.00 | 23.9x | -32.2x | 5.3x |
Mon, 05 Jun 2023 | UK£7.0b | UK£1.3b | -UK£204,603,564.00 | 22.6x | -34.3x | 5.6x |
Wed, 03 May 2023 | UK£7.1b | UK£1.3b | -UK£206,395,552.00 | 23.7x | -34.2x | 5.6x |
Fri, 31 Mar 2023 | UK£7.2b | UK£1.2b | -UK£154,920,420.00 | 24x | -46.2x | 5.8x |
Sun, 26 Feb 2023 | UK£7.4b | UK£1.2b | -UK£156,977,013.00 | 26.1x | -47.4x | 6x |
Tue, 24 Jan 2023 | UK£7.6b | UK£1.2b | -UK£140,066,429.00 | 27.6x | -54.6x | 6.6x |
Thu, 22 Dec 2022 | UK£7.5b | UK£1.2b | -UK£138,236,364.00 | 26.7x | -54x | 6.4x |
Sat, 19 Nov 2022 | UK£7.8b | UK£1.2b | -UK£139,984,413.00 | 25.1x | -55.6x | 6.7x |
Mon, 17 Oct 2022 | UK£7.0b | UK£1.2b | -UK£150,681,291.00 | 26.2x | -46.7x | 6.1x |
Wed, 14 Sep 2022 | UK£7.6b | UK£1.1b | -UK£144,420,164.00 | 35.4x | -52.4x | 6.6x |
Fri, 12 Aug 2022 | UK£7.5b | UK£1.1b | -UK£200,200,136.00 | 37.6x | -37.3x | 6.7x |
Sun, 10 Jul 2022 | UK£7.1b | UK£1.1b | -UK£175,037,886.00 | 36.3x | -40.4x | 6.3x |
Tue, 07 Jun 2022 | UK£7.2b | UK£1.1b | -UK£156,741,499.00 | 38.4x | -46x | 6.5x |
-46x
Which industries have driven the changes within the U.K. Healthcare industry?
GB Market | 0.58% | |
Healthcare | 2.88% | |
Biotech | 1.91% | |
Biotech | 1.91% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
FARN Faron Pharmaceuticals Oy | UK£2.63 | 11.7% +UK£47.4m | 41.9% | PE-15.6x | |
AVCT Avacta Group | UK£0.38 | 38.2% +UK£40.9m | -5.9% | PS6.6x | |
OXB Oxford Biomedica | UK£3.25 | 1.6% +UK£5.3m | -1.8% | PS2.7x | |
PRTC PureTech Health | UK£1.36 | 0.9% +UK£2.9m | -41.8% | PE8.2x | |
PBX ProBiotix Health | UK£0.083 | 22.2% +UK£2.4m | 65.0% | PS6.9x |